APP and Alzheimer disease: Aβ complexes of similar size, most often referred to as Aβ*56, have been observed in transgenic APP mouse models (Lesné et al., 2006) and human AD brains (Lesné et al., 2013), and their levels have been proposed to correlate with cognitive impairment and toxicity.